Nagpal Kamal, Zinman Leonard N, Lebeis Christopher, Vanni Alex J, Buckley Jill C
Institute of Urology, Lahey Hospital and Medical Center, Burlington, Massachusetts.
Department of Urology, UC San Diego Health System, San Diego, California.
Urol Pract. 2015 Sep;2(5):250-255. doi: 10.1016/j.urpr.2014.12.007. Epub 2015 Jul 1.
We evaluated our intermediate term experience with radial urethrotomy and intralesional mitomycin C injection in patients with recurrent bladder neck contractures. Recurrent bladder neck contractures in which previous endoscopic treatment failed pose a difficult management dilemma.
Prospectively collected data were reviewed in a retrospective manner of patients presenting with recurrent bladder neck contractures from January 2007 to June 2014. All patients had at least 1 prior failed incision of a bladder neck contracture and many had additional dilations or catheter dependence. Radial cold knife incisions of the bladder neck were performed followed by injection of 0.3 to 0.4 mg/ml mitomycin C at each incision site. All surgeons performed the incision technique and injection in a reproducible fashion.
A total of 40 patients underwent urethrotomy with mitomycin C injection. At a median followup of 20.5 months 30 patients (75.0%) had a stable bladder neck after 1 procedure. An additional 5 patients required 2 procedures to obtain a stable patent bladder neck (87.5%). Of the 40 patients 14 (35.0%) presented in retention on catheter drainage and all had a stable, patent bladder neck. No recurrence was detected in the original 18 patients in the pilot study with patent bladder necks. Rigorous followup revealed no long-term complications.
Urethrotomy with mitomycin C injection for the management of recurrent bladder neck contractures is safe and efficacious. The addition of an antifibrotic agent in conjunction with internal urethrotomy offers a definitive solution to a problem that would otherwise be managed with repeat urethral incision/dilation, catheter dependence or open bladder neck reconstruction.
我们评估了对复发性膀胱颈挛缩患者行尿道放射状切开及病灶内注射丝裂霉素C的中期经验。既往内镜治疗失败的复发性膀胱颈挛缩给治疗带来了难题。
回顾性分析2007年1月至2014年6月期间出现复发性膀胱颈挛缩患者的前瞻性收集数据。所有患者既往至少有1次膀胱颈挛缩切开失败,许多患者还接受过额外的扩张或依赖导尿管。对膀胱颈进行放射状冷刀切开,然后在每个切开部位注射0.3至0.4mg/ml的丝裂霉素C。所有外科医生均以可重复的方式进行切开技术和注射操作。
共有40例患者接受了尿道切开并注射丝裂霉素C。中位随访20.5个月时,30例患者(75.0%)经1次手术膀胱颈保持稳定。另有5例患者需要2次手术才能获得稳定的通畅膀胱颈(87.5%)。40例患者中,14例(35.0%)在留置导尿管引流时就诊,所有患者的膀胱颈均稳定且通畅。在初步研究中,最初18例膀胱颈通畅的患者未检测到复发。严格随访未发现长期并发症。
尿道切开并注射丝裂霉素C治疗复发性膀胱颈挛缩安全有效。在尿道内切开术中加入抗纤维化药物为一个问题提供了确定性解决方案,否则该问题需通过重复尿道切开/扩张、依赖导尿管或开放性膀胱颈重建来处理。